Company / SG&A Expense
Oscar Health, Inc. SG&A Expense History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$2.0B
FY2025
5-year range
$110.7M / $2.0B
FY2021-FY2025
Trend
+16.8%
vs FY2024
Sector context
#27 of 158
Health Care
What the data says
Oscar Health, Inc.'s sg&a expense of $2.0B is higher than 83% of companies in the Health Care sector (FY2025). SG&A Expense has increased for 4 consecutive years, from $111M in FY2021 to $2.0B in FY2025.
Based on SEC 10-K filings.
$2.0B in FY2025 with a 5-year CAGR of +65.2%. Top quartile in the Health Care sector.
Increased from $265M to $2.0B over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +130.8%
- 5-Year CAGR
- +65.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 158This company $2.0B Sector average $175.9B
▼
-98.8% below sector average
Key checks
Key Insights
- Oscar Health, Inc.'s sg&a expense has grown for 4 consecutive years.
- 5-year CAGR of +65.2%, indicating consistent growth.
- In FY2025, sg&a expense increased 16.8% year-over-year.
- Ranks #27 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.0B | +16.8% |
| FY2024 | $1.8B | +562.3% |
| FY2023 | $265.1M | +59.1% |
| FY2022 | $166.7M | +50.6% |
| FY2021 | $110.7M | -33.6% |
| FY2020 | $166.7M | +50.6% |
| FY2019 | $110.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026